PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
06-Nov-2019 Q BioMed Announces $7.5M Grant Benefiting its Preclinical Product Development Pipeline Q BioMed
06-Nov-2019 EACS 2019: ViiV Healthcare to present 17 abstracts from its portfolio addressing the diverse needs of people living with HIV ViiV Healthcare
06-Nov-2019 Artios Pharma, MD Anderson and ShangPharma announce in-licensing agreement for DNA damage response inhibitor Artios Pharma Limited
06-Nov-2019 Urania Therapeutics closes a €3.5M initial seed round Urania Therapeutics
06-Nov-2019 Cells that could lead to new therapies: PromoCell now offers in vitro disease models PromoCell
06-Nov-2019 Wiley Partners With Editage to Enhance and Expand Services for Authors Cactus Communications
06-Nov-2019 FLOURISH THROUGH THE MENOPAUSE Flourish
06-Nov-2019 Autolus Therapeutics Receives FDA Orphan Drug Designation for AUTO1 for Treatment of Acute Lymphoblastic Leukemia Autolus Therapeutics plc
06-Nov-2019 PureTech Affiliate Gelesis Presents Additional Data Highlighting Therapeutic Benefits of PlenityTM at ObesityWeek 2019 PureTech
06-Nov-2019 Next generation PAS-X MES speeds up biotech and cell & gene manufacturing Werum IT Solutions GmbH
06-Nov-2019 Complimentary Webinar: Preparing for an ISO 17025 Audit: What to expect from a LIMS? CloudLIMS
06-Nov-2019 Edwards SAPIEN 3 TAVI Receives Expanded Approval In Europe Edwards Lifesciences Corporation
06-Nov-2019 First Paralyzed American Completes a Marathon Using a ReWalk Exoskeleton ReWalk Robotics, Ltd.
05-Nov-2019 FDA authorizes marketing of first next-generation sequencing test for detecting HIV-1 drug resistance mutations U.S. Food and Drug Administration
05-Nov-2019 Masters Speciality Pharma Announces Launch of Neuropad® in Brazil for Detection of Diabetic Foot Syndrome Masters Speciality Pharma
05-Nov-2019 SMi’s 22nd Annual Superbugs & Superdrugs Conference 2020 – Speakers Announced & Brochure Released SMi Group
05-Nov-2019 PureTech Announces Presentation of New Data Supporting Wholly Owned Immuno-Oncology Programmes LYT-200 (anti-galectin-9) and LYT-210 (anti-delta-1) PureTech Health plc
05-Nov-2019 Kayentis opens Japanese subsidiary to support growth of Asia-Pacific clinical trials sector Kayentis
05-Nov-2019 Mallinckrodt plc Announces Exchange Offers and Consent Solicitations Mallinckrodt plc
05-Nov-2019 Mallinckrodt plc Reports Earnings and Pipeline Advancements for the Third Quarter 2019 and Raises Adjusted Diluted Earnings Per Share Guidance Range for 2019 Mallinckrodt plc